Hua-Jing Ni

Emerging therapies for diabetic kidney disease: beyond SGLT2 inhibitors

ABSTRACT Introduction Diabetic kidney disease (DKD) remains the leading cause of kidney failure and death worldwide despite established therapies targeting the renin–angiotensin system and, more recently, sodium glucose cotransporter-2 inhibitors. Although contemporary guideline-directed therapy has substantially impro...